Cizzle Biotechnology Holdings Plc (LON:CIZ)
London · Delayed Price · Currency is GBP · Price in GBX 1.600
-0.100 (-5.88%)
Sep 25, 2026, 3:10 PM GMT
LON:CIZ Market Cap
LON:CIZ has a market cap or net worth of 7.22 million as of September 25, 2026. Its market cap has increased by 4.14% in one year.
Market Cap
7.22M
Enterprise Value
7.11M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.60
ChartMarket Cap Chart
Since May 14, 2021, LON:CIZ's market cap has decreased from 23.76M to 7.22M, a decrease of -69.60%. That is a compound annual growth rate of -19.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 7.22M | 17.58% |
| Dec 31, 2025 | 6.14M | - |
| Dec 31, 2024 | 6.14M | -13.40% |
| Dec 29, 2023 | 7.09M | 40.94% |
| Dec 30, 2022 | 5.03M | -33.79% |
| Dec 31, 2021 | 7.60M | -68.00% |
| May 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oxford BioDynamics | 15.46M |
| Fusion Antibodies | 15.02M |
| Palatin Technologies | 12.90M |
| Aptamer Group | 11.23M |
| Genflow Biosciences | 10.90M |
| Solvonis Therapeutics | 7.83M |
| CRISM Therapeutics | 7.72M |
| Thalia Therapeutics | 6.95M |